You are here:

European Drug Report 2022: Trends and Developments

posted 23/06/2022

publication EMCDDA

Preface The European Drug Report (EDR) 2022 arrives at a time when recent major global events have impacted profoundly on all areas of our life and therefore also have implications for the drug problems we are facing in Europe today. Our flagship report is designed to help Europe be better prepared to meet these challenges. It does this by analysing both the trends that are shaping the current situation, and by identifying emerging threats that may impact on the drug problems Europe will face in the future. It is important to note that this analysis does not stand alone but is supported by a large body of recent work. As always, we accompany this year’s EDR with our Statistical Bulletin, which provides access to the underlying data and methodological notes and caveats. This report also draws heavily on recent reviews, conducted in partnership with Europol, of developments in the cocaine and methamphetamine markets. These studies show the increasingly important role stimulants now play in the European drug problem. This year also marks 25 years of the work of the EU Early Warning System on new psychoactive substances. This milestone is celebrated in an accompanying review of the achievements of this ground-breaking network

get involved

If you are interested in what we do and would like to support our work, find out more ways to get involved.


get our book

Drugs: It’s just not worth it

Drugs: It’s just not worth it

Our 35-page book gives clear and easy to read facts and advice aimed at teenagers and young people.


Buy Now